Schedule 13G ownership disclosure
CHINA SXT PHARMACEUTICALS IN
Security class unavailable · CUSIP: G2161P140
Event date: 2024-02-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 38.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-012689
- Form type
- SC 13G
- Filer
- China SXT Pharmaceuticals, Inc.
- CIK
- CIK 1723980
- Filed
- Feb 09, 2024
- Reporting period
- Feb 08, 2024
- Description
- Schedule 13G beneficial ownership